

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 6.35623955 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 6.35623955 |
| 3 | exogenous drug catabolic process (GO:0042738) | 5.97191790 |
| 4 | drug catabolic process (GO:0042737) | 5.54305756 |
| 5 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.36336677 |
| 6 | protein retention in ER lumen (GO:0006621) | 5.16677127 |
| 7 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.90461714 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 4.67262236 |
| 9 | glucuronate metabolic process (GO:0019585) | 4.67018187 |
| 10 | uronic acid metabolic process (GO:0006063) | 4.67018187 |
| 11 | cellular glucuronidation (GO:0052695) | 4.62412373 |
| 12 | ethanol oxidation (GO:0006069) | 4.37512158 |
| 13 | omega-hydroxylase P450 pathway (GO:0097267) | 4.31133406 |
| 14 | ethanol metabolic process (GO:0006067) | 4.16712213 |
| 15 | axonemal dynein complex assembly (GO:0070286) | 4.14937994 |
| 16 | primary alcohol catabolic process (GO:0034310) | 4.10940345 |
| 17 | signal peptide processing (GO:0006465) | 3.97038731 |
| 18 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.95336949 |
| 19 | cellular ketone body metabolic process (GO:0046950) | 3.89157147 |
| 20 | cilium movement (GO:0003341) | 3.84673363 |
| 21 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.78377775 |
| 22 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.70543624 |
| 23 | exocrine pancreas development (GO:0031017) | 3.70425301 |
| 24 | epithelial cilium movement (GO:0003351) | 3.70272278 |
| 25 | drug metabolic process (GO:0017144) | 3.70091002 |
| 26 | phenylpropanoid metabolic process (GO:0009698) | 3.68575971 |
| 27 | protein maturation by protein folding (GO:0022417) | 3.65472653 |
| 28 | COPII vesicle coating (GO:0048208) | 3.59261301 |
| 29 | ER overload response (GO:0006983) | 3.58123762 |
| 30 | bile acid biosynthetic process (GO:0006699) | 3.48688904 |
| 31 | glyoxylate metabolic process (GO:0046487) | 3.44430530 |
| 32 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.42911061 |
| 33 | oxidative demethylation (GO:0070989) | 3.41286162 |
| 34 | ketone body metabolic process (GO:1902224) | 3.39358809 |
| 35 | amino-acid betaine metabolic process (GO:0006577) | 3.37805089 |
| 36 | bile acid metabolic process (GO:0008206) | 3.36415205 |
| 37 | peptide hormone processing (GO:0016486) | 3.34033562 |
| 38 | flavonoid metabolic process (GO:0009812) | 3.31277443 |
| 39 | indole-containing compound catabolic process (GO:0042436) | 3.29829463 |
| 40 | indolalkylamine catabolic process (GO:0046218) | 3.29829463 |
| 41 | tryptophan catabolic process (GO:0006569) | 3.29829463 |
| 42 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.28457498 |
| 43 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.27906924 |
| 44 | axoneme assembly (GO:0035082) | 3.25724694 |
| 45 | endocrine pancreas development (GO:0031018) | 3.24386490 |
| 46 | S-adenosylmethionine metabolic process (GO:0046500) | 3.23647805 |
| 47 | aromatic amino acid family catabolic process (GO:0009074) | 3.19679903 |
| 48 | bile acid and bile salt transport (GO:0015721) | 3.19489051 |
| 49 | benzene-containing compound metabolic process (GO:0042537) | 3.19252611 |
| 50 | nucleobase catabolic process (GO:0046113) | 3.16121461 |
| 51 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.15226718 |
| 52 | insulin secretion (GO:0030073) | 3.10621828 |
| 53 | protein targeting to Golgi (GO:0000042) | 3.10188498 |
| 54 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.08261649 |
| 55 | L-phenylalanine catabolic process (GO:0006559) | 3.08261649 |
| 56 | positive regulation of insulin secretion (GO:0032024) | 3.08173791 |
| 57 | vesicle coating (GO:0006901) | 3.06992387 |
| 58 | regulation of protein activation cascade (GO:2000257) | 3.06377192 |
| 59 | positive regulation of nuclease activity (GO:0032075) | 3.02747270 |
| 60 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.01885274 |
| 61 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.99862309 |
| 62 | detection of calcium ion (GO:0005513) | 2.98976507 |
| 63 | regulation of complement activation (GO:0030449) | 2.96205458 |
| 64 | alkaloid metabolic process (GO:0009820) | 2.95506941 |
| 65 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.95350373 |
| 66 | primary alcohol metabolic process (GO:0034308) | 2.94680546 |
| 67 | protein localization to cilium (GO:0061512) | 2.94070016 |
| 68 | type B pancreatic cell development (GO:0003323) | 2.92267286 |
| 69 | protein localization to Golgi apparatus (GO:0034067) | 2.90114026 |
| 70 | xenobiotic catabolic process (GO:0042178) | 2.87546066 |
| 71 | establishment of protein localization to Golgi (GO:0072600) | 2.86245545 |
| 72 | regulation of triglyceride catabolic process (GO:0010896) | 2.84910751 |
| 73 | glandular epithelial cell differentiation (GO:0002067) | 2.83206623 |
| 74 | sequestering of metal ion (GO:0051238) | 2.82428372 |
| 75 | macroautophagy (GO:0016236) | 2.77991113 |
| 76 | xenobiotic metabolic process (GO:0006805) | 2.77708018 |
| 77 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.77480540 |
| 78 | regulation of synaptic vesicle transport (GO:1902803) | 2.77427848 |
| 79 | drug transmembrane transport (GO:0006855) | 2.76983351 |
| 80 | indolalkylamine metabolic process (GO:0006586) | 2.75756529 |
| 81 | negative regulation of protein activation cascade (GO:2000258) | 2.73279849 |
| 82 | cellular response to unfolded protein (GO:0034620) | 2.72608974 |
| 83 | regulation of insulin secretion (GO:0050796) | 2.72432185 |
| 84 | ER-nucleus signaling pathway (GO:0006984) | 2.69998170 |
| 85 | complement activation, alternative pathway (GO:0006957) | 2.68901873 |
| 86 | regulation of nuclease activity (GO:0032069) | 2.68013140 |
| 87 | cellular response to topologically incorrect protein (GO:0035967) | 2.67928038 |
| 88 | tryptophan metabolic process (GO:0006568) | 2.67403144 |
| 89 | L-fucose catabolic process (GO:0042355) | 2.65686715 |
| 90 | fucose catabolic process (GO:0019317) | 2.65686715 |
| 91 | L-fucose metabolic process (GO:0042354) | 2.65686715 |
| 92 | triglyceride homeostasis (GO:0070328) | 2.64456337 |
| 93 | acylglycerol homeostasis (GO:0055090) | 2.64456337 |
| 94 | L-phenylalanine metabolic process (GO:0006558) | 2.64375555 |
| 95 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.64375555 |
| 96 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.64359032 |
| 97 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.63604790 |
| 98 | synaptic vesicle maturation (GO:0016188) | 2.63366487 |
| 99 | positive regulation of peptide hormone secretion (GO:0090277) | 2.62362762 |
| 100 | coenzyme catabolic process (GO:0009109) | 2.61424611 |
| 101 | peptidyl-asparagine modification (GO:0018196) | 2.61142449 |
| 102 | positive regulation of peptide secretion (GO:0002793) | 2.59945964 |
| 103 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.59488093 |
| 104 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.59488093 |
| 105 | prostate gland growth (GO:0060736) | 2.57048736 |
| 106 | negative regulation of complement activation (GO:0045916) | 2.56618552 |
| 107 | regulation of fibrinolysis (GO:0051917) | 2.54867337 |
| 108 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.54539554 |
| 109 | daunorubicin metabolic process (GO:0044597) | 2.50674364 |
| 110 | polyketide metabolic process (GO:0030638) | 2.50674364 |
| 111 | doxorubicin metabolic process (GO:0044598) | 2.50674364 |
| 112 | arginine metabolic process (GO:0006525) | 2.50144829 |
| 113 | regulation of peptide hormone secretion (GO:0090276) | 2.49882251 |
| 114 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.49849216 |
| 115 | regulation of peptide secretion (GO:0002791) | 2.49208491 |
| 116 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.46148536 |
| 117 | kynurenine metabolic process (GO:0070189) | 2.45907705 |
| 118 | protein N-linked glycosylation (GO:0006487) | 2.45602689 |
| 119 | fucose metabolic process (GO:0006004) | 2.45511666 |
| 120 | aldehyde catabolic process (GO:0046185) | 2.44778163 |
| 121 | negative regulation of humoral immune response (GO:0002921) | 2.43845483 |
| 122 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.43607872 |
| 123 | androgen metabolic process (GO:0008209) | 2.43305277 |
| 124 | regulation of ARF protein signal transduction (GO:0032012) | 2.43134956 |
| 125 | intestinal cholesterol absorption (GO:0030299) | 2.42478143 |
| 126 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.41090048 |
| 127 | response to endoplasmic reticulum stress (GO:0034976) | 2.40784364 |
| 128 | Golgi organization (GO:0007030) | 2.39216107 |
| 129 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.38619573 |
| 130 | positive regulation of vesicle fusion (GO:0031340) | 2.37833023 |
| 131 | glandular epithelial cell development (GO:0002068) | 2.37541738 |
| 132 | regulation of autophagic vacuole assembly (GO:2000785) | 2.36440938 |
| 133 | regulation of cilium movement (GO:0003352) | 2.35228099 |
| 134 | cilium organization (GO:0044782) | 2.35143141 |
| 135 | neurotransmitter metabolic process (GO:0042133) | 2.34297031 |
| 136 | complement activation, classical pathway (GO:0006958) | 2.34118675 |
| 137 | behavioral response to nicotine (GO:0035095) | 2.33987569 |
| 138 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.33694932 |
| 139 | positive regulation of exocytosis (GO:0045921) | 2.32871657 |
| 140 | intestinal epithelial cell development (GO:0060576) | 2.31270915 |
| 141 | toxin metabolic process (GO:0009404) | 2.31029802 |
| 142 | neurotransmitter biosynthetic process (GO:0042136) | 2.30917088 |
| 143 | synaptic vesicle exocytosis (GO:0016079) | 2.30256878 |
| 144 | regulation of steroid hormone secretion (GO:2000831) | 2.30106458 |
| 145 | cilium assembly (GO:0042384) | 2.30085960 |
| 146 | response to pheromone (GO:0019236) | 2.29985145 |
| 147 | response to nitrosative stress (GO:0051409) | 2.29766833 |
| 148 | regulation of beta-amyloid formation (GO:1902003) | 2.29483577 |
| 149 | peptide secretion (GO:0002790) | 2.28541789 |
| 150 | cellular response to glucagon stimulus (GO:0071377) | 2.28479779 |
| 151 | mitochondrial calcium ion transport (GO:0006851) | 2.28170253 |
| 152 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.27870291 |
| 153 | regulation of hormone secretion (GO:0046883) | 2.26265891 |
| 154 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.25061119 |
| 155 | neurotransmitter catabolic process (GO:0042135) | 2.24827149 |
| 156 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.23760105 |
| 157 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.23496699 |
| 158 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.23086055 |
| 159 | quinone metabolic process (GO:1901661) | 2.22930789 |
| 160 | carnitine metabolic process (GO:0009437) | 2.22702380 |
| 161 | peptide hormone secretion (GO:0030072) | 2.22684418 |
| 162 | retinal metabolic process (GO:0042574) | 2.22204426 |
| 163 | Golgi vesicle transport (GO:0048193) | 2.21927527 |
| 164 | positive regulation of fatty acid oxidation (GO:0046321) | 2.21735902 |
| 165 | reflex (GO:0060004) | 2.21300205 |
| 166 | cilium morphogenesis (GO:0060271) | 2.20551763 |
| 167 | positive regulation of glycolytic process (GO:0045821) | 2.20069496 |
| 168 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.19993141 |
| 169 | indole-containing compound metabolic process (GO:0042430) | 2.19778270 |
| 170 | hormone catabolic process (GO:0042447) | 2.19761770 |
| 171 | negative regulation of glycogen metabolic process (GO:0070874) | 2.19472710 |
| 172 | retinol metabolic process (GO:0042572) | 2.19279879 |
| 173 | regulation of glucocorticoid secretion (GO:2000849) | 2.19133084 |
| 174 | androgen biosynthetic process (GO:0006702) | 2.19024251 |
| 175 | positive regulation of hormone secretion (GO:0046887) | 2.18492451 |
| 176 | regulation of exocytosis (GO:0017157) | 2.17907812 |
| 177 | N-glycan processing (GO:0006491) | 2.17605537 |
| 178 | fucosylation (GO:0036065) | 2.16311192 |
| 179 | magnesium ion transport (GO:0015693) | 2.14177771 |
| 180 | response to ischemia (GO:0002931) | 2.12562459 |
| 181 | positive regulation of regulated secretory pathway (GO:1903307) | 2.08395962 |
| 182 | activation of protein kinase A activity (GO:0034199) | 2.07860606 |
| 183 | GDP-mannose metabolic process (GO:0019673) | 2.07320042 |
| 184 | nucleoside diphosphate catabolic process (GO:0009134) | 2.07111899 |
| 185 | relaxation of cardiac muscle (GO:0055119) | 2.05455047 |
| 186 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.03880615 |
| 187 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.03739834 |
| 188 | regulation of peptide transport (GO:0090087) | 2.02992173 |
| 189 | response to redox state (GO:0051775) | 2.02832980 |
| 190 | glutamate secretion (GO:0014047) | 2.02764288 |
| 191 | peptide transport (GO:0015833) | 2.02747344 |
| 192 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.01241624 |
| 193 | response to unfolded protein (GO:0006986) | 2.00835576 |
| 194 | regulation of vesicle fusion (GO:0031338) | 2.00465951 |
| 195 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.00118335 |
| 196 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 1.99770608 |
| 197 | digestion (GO:0007586) | 1.99102001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.63842551 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.37830328 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 2.11886083 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.94630798 |
| 5 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.92374421 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.89448415 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.80267063 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 1.78671723 |
| 9 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.77324878 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.76265820 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.73242335 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.71895243 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.61791945 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.61256367 |
| 15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.58597388 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.56858315 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56249292 |
| 18 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.54420002 |
| 19 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.53918534 |
| 20 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.52454722 |
| 21 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.52120015 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.49315942 |
| 23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.48034132 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.46007891 |
| 25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.39750269 |
| 26 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.37452074 |
| 27 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33959822 |
| 28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.33622690 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31611296 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.30451873 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.29337863 |
| 32 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28751339 |
| 33 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.27493375 |
| 34 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24927616 |
| 35 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.24652773 |
| 36 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24394215 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24188716 |
| 38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.22978177 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22528933 |
| 40 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.21012990 |
| 41 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.20801816 |
| 42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.20610774 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20537715 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.19627541 |
| 45 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17814518 |
| 46 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17803310 |
| 47 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17551426 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16400608 |
| 49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16003455 |
| 50 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.15971676 |
| 51 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.15971676 |
| 52 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.15799354 |
| 53 | FUS_26573619_Chip-Seq_HEK293_Human | 1.15016814 |
| 54 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.14643502 |
| 55 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.14643502 |
| 56 | CJUN_26792858_Chip-Seq_BT549_Human | 1.13206512 |
| 57 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.13110560 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13086222 |
| 59 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12991979 |
| 60 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.12615038 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11473664 |
| 62 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.10947901 |
| 63 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.10703844 |
| 64 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.10113062 |
| 65 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09226058 |
| 66 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.09011294 |
| 67 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08877073 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08706722 |
| 69 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.08429523 |
| 70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08359222 |
| 71 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08359222 |
| 72 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07859338 |
| 73 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07644748 |
| 74 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.07273986 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06093485 |
| 76 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05820977 |
| 77 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04134917 |
| 78 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03578684 |
| 79 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03153771 |
| 80 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.02134936 |
| 81 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02067644 |
| 82 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.01306964 |
| 83 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.00915097 |
| 84 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.00591800 |
| 85 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.00550516 |
| 86 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.00317898 |
| 87 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.00185124 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00070653 |
| 89 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.99948779 |
| 90 | EWS_26573619_Chip-Seq_HEK293_Human | 0.99821395 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99799209 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99337146 |
| 93 | STAT3_23295773_ChIP-Seq_U87_Human | 0.99063086 |
| 94 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.99053492 |
| 95 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98837327 |
| 96 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.98823885 |
| 97 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98327224 |
| 98 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97685747 |
| 99 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96220972 |
| 100 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.96210486 |
| 101 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.96150682 |
| 102 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.95517987 |
| 103 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95172337 |
| 104 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.95137341 |
| 105 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.95137341 |
| 106 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.94997034 |
| 107 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.94997034 |
| 108 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.94498999 |
| 109 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94401901 |
| 110 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94258821 |
| 111 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.94167348 |
| 112 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92781082 |
| 113 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89808334 |
| 114 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89459759 |
| 115 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.87762703 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87539304 |
| 117 | P300_19829295_ChIP-Seq_ESCs_Human | 0.87324842 |
| 118 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87087664 |
| 119 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86938341 |
| 120 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.86877040 |
| 121 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84907552 |
| 122 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84256564 |
| 123 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.83936177 |
| 124 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.83494226 |
| 125 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.82988757 |
| 126 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82704406 |
| 127 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.82494308 |
| 128 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82428292 |
| 129 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.82040616 |
| 130 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81667918 |
| 131 | TCF4_23295773_ChIP-Seq_U87_Human | 0.80526598 |
| 132 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.80427269 |
| 133 | SPI1_23127762_ChIP-Seq_K562_Human | 0.79808152 |
| 134 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.79273869 |
| 135 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78970809 |
| 136 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.78267757 |
| 137 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.77446556 |
| 138 | RXR_22108803_ChIP-Seq_LS180_Human | 0.77192151 |
| 139 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.77101668 |
| 140 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.76971978 |
| 141 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.76733701 |
| 142 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.76524933 |
| 143 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.75820206 |
| 144 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.74702329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010386_abnormal_urinary_bladder | 3.53458864 |
| 2 | MP0002909_abnormal_adrenal_gland | 3.41353800 |
| 3 | MP0003183_abnormal_peptide_metabolism | 3.19677149 |
| 4 | MP0009780_abnormal_chondrocyte_physiolo | 2.96228034 |
| 5 | MP0002693_abnormal_pancreas_physiology | 2.88899296 |
| 6 | MP0000013_abnormal_adipose_tissue | 2.86264248 |
| 7 | MP0005646_abnormal_pituitary_gland | 2.59926250 |
| 8 | MP0001944_abnormal_pancreas_morphology | 2.57019176 |
| 9 | MP0004043_abnormal_pH_regulation | 2.52138126 |
| 10 | MP0003195_calcinosis | 2.39128293 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.36722384 |
| 12 | MP0005220_abnormal_exocrine_pancreas | 2.34391577 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.20788927 |
| 14 | MP0005360_urolithiasis | 2.12866307 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.12497529 |
| 16 | MP0005379_endocrine/exocrine_gland_phen | 2.11783432 |
| 17 | MP0001986_abnormal_taste_sensitivity | 2.07756518 |
| 18 | MP0004859_abnormal_synaptic_plasticity | 2.04888761 |
| 19 | MP0005365_abnormal_bile_salt | 1.98568768 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 1.92068258 |
| 21 | MP0003011_delayed_dark_adaptation | 1.88340442 |
| 22 | MP0005310_abnormal_salivary_gland | 1.87394777 |
| 23 | MP0003283_abnormal_digestive_organ | 1.83378459 |
| 24 | MP0004270_analgesia | 1.81721760 |
| 25 | MP0001765_abnormal_ion_homeostasis | 1.72071059 |
| 26 | MP0008872_abnormal_physiological_respon | 1.70615726 |
| 27 | MP0002078_abnormal_glucose_homeostasis | 1.69167443 |
| 28 | MP0005332_abnormal_amino_acid | 1.68878184 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.66441330 |
| 30 | MP0000427_abnormal_hair_cycle | 1.63688509 |
| 31 | MP0009046_muscle_twitch | 1.63401775 |
| 32 | MP0003868_abnormal_feces_composition | 1.63296388 |
| 33 | MP0000003_abnormal_adipose_tissue | 1.59528149 |
| 34 | MP0004510_myositis | 1.54713610 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.53553881 |
| 36 | MP0001502_abnormal_circadian_rhythm | 1.53244622 |
| 37 | MP0005645_abnormal_hypothalamus_physiol | 1.51916642 |
| 38 | MP0004019_abnormal_vitamin_homeostasis | 1.50575005 |
| 39 | MP0000678_abnormal_parathyroid_gland | 1.50130296 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 1.48055728 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.45201882 |
| 42 | MP0003635_abnormal_synaptic_transmissio | 1.41015254 |
| 43 | MP0001968_abnormal_touch/_nociception | 1.40427899 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.39333505 |
| 45 | MP0005551_abnormal_eye_electrophysiolog | 1.39055177 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.38020958 |
| 47 | MP0002928_abnormal_bile_duct | 1.37753948 |
| 48 | MP0002734_abnormal_mechanical_nocicepti | 1.33262544 |
| 49 | MP0003787_abnormal_imprinting | 1.32368828 |
| 50 | MP0002733_abnormal_thermal_nociception | 1.27917723 |
| 51 | MP0002653_abnormal_ependyma_morphology | 1.23495452 |
| 52 | MP0002139_abnormal_hepatobiliary_system | 1.23265154 |
| 53 | MP0003252_abnormal_bile_duct | 1.21070173 |
| 54 | MP0003953_abnormal_hormone_level | 1.20951126 |
| 55 | MP0000639_abnormal_adrenal_gland | 1.20896317 |
| 56 | MP0002736_abnormal_nociception_after | 1.20830124 |
| 57 | MP0001970_abnormal_pain_threshold | 1.20660239 |
| 58 | MP0010234_abnormal_vibrissa_follicle | 1.19602350 |
| 59 | MP0005535_abnormal_body_temperature | 1.16628748 |
| 60 | MP0005503_abnormal_tendon_morphology | 1.13808171 |
| 61 | MP0008961_abnormal_basal_metabolism | 1.12624700 |
| 62 | MP0000383_abnormal_hair_follicle | 1.10597690 |
| 63 | MP0002822_catalepsy | 1.10032135 |
| 64 | MP0009643_abnormal_urine_homeostasis | 1.09971922 |
| 65 | MP0002009_preneoplasia | 1.08194880 |
| 66 | MP0006276_abnormal_autonomic_nervous | 1.06600219 |
| 67 | MP0003866_abnormal_defecation | 1.06482899 |
| 68 | MP0001485_abnormal_pinna_reflex | 1.05520042 |
| 69 | MP0004885_abnormal_endolymph | 1.05269232 |
| 70 | MP0001664_abnormal_digestion | 1.04767798 |
| 71 | MP0000230_abnormal_systemic_arterial | 1.04220963 |
| 72 | MP0002272_abnormal_nervous_system | 1.04132698 |
| 73 | MP0010678_abnormal_skin_adnexa | 1.02737339 |
| 74 | MP0002166_altered_tumor_susceptibility | 1.02545335 |
| 75 | MP0001756_abnormal_urination | 1.01416335 |
| 76 | MP0004133_heterotaxia | 1.00906672 |
| 77 | MP0006072_abnormal_retinal_apoptosis | 1.00606362 |
| 78 | MP0003879_abnormal_hair_cell | 1.00536777 |
| 79 | MP0004264_abnormal_extraembryonic_tissu | 1.00439131 |
| 80 | MP0002063_abnormal_learning/memory/cond | 1.00332680 |
| 81 | MP0003329_amyloid_beta_deposits | 1.00073050 |
| 82 | MP0002638_abnormal_pupillary_reflex | 1.00066773 |
| 83 | MP0001501_abnormal_sleep_pattern | 0.99637302 |
| 84 | MP0000613_abnormal_salivary_gland | 0.99195114 |
| 85 | MP0000538_abnormal_urinary_bladder | 0.98195511 |
| 86 | MP0009745_abnormal_behavioral_response | 0.98187410 |
| 87 | MP0000681_abnormal_thyroid_gland | 0.98073231 |
| 88 | MP0002572_abnormal_emotion/affect_behav | 0.98001777 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 0.96155972 |
| 90 | MP0002102_abnormal_ear_morphology | 0.95804199 |
| 91 | MP0002168_other_aberrant_phenotype | 0.94241849 |
| 92 | MP0005253_abnormal_eye_physiology | 0.92299544 |
| 93 | MP0001486_abnormal_startle_reflex | 0.91937053 |
| 94 | MP0002282_abnormal_trachea_morphology | 0.91855659 |
| 95 | MP0005083_abnormal_biliary_tract | 0.91330994 |
| 96 | MP0002118_abnormal_lipid_homeostasis | 0.91107095 |
| 97 | MP0000462_abnormal_digestive_system | 0.91052575 |
| 98 | MP0001984_abnormal_olfaction | 0.90830876 |
| 99 | MP0002064_seizures | 0.89523154 |
| 100 | MP0003633_abnormal_nervous_system | 0.89449975 |
| 101 | MP0002557_abnormal_social/conspecific_i | 0.88698925 |
| 102 | MP0000569_abnormal_digit_pigmentation | 0.88492252 |
| 103 | MP0001873_stomach_inflammation | 0.87549402 |
| 104 | MP0002277_abnormal_respiratory_mucosa | 0.82506810 |
| 105 | MP0004142_abnormal_muscle_tone | 0.82037475 |
| 106 | MP0001835_abnormal_antigen_presentation | 0.81543042 |
| 107 | MP0004883_abnormal_blood_vessel | 0.80827841 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.80721104 |
| 109 | MP0001270_distended_abdomen | 0.79763173 |
| 110 | MP0002138_abnormal_hepatobiliary_system | 0.79550510 |
| 111 | MP0001790_abnormal_immune_system | 0.78838584 |
| 112 | MP0005387_immune_system_phenotype | 0.78838584 |
| 113 | MP0003880_abnormal_central_pattern | 0.78222561 |
| 114 | MP0008569_lethality_at_weaning | 0.76419173 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.75813865 |
| 116 | MP0001764_abnormal_homeostasis | 0.75732151 |
| 117 | MP0002163_abnormal_gland_morphology | 0.75617139 |
| 118 | MP0002067_abnormal_sensory_capabilities | 0.74752768 |
| 119 | MP0005448_abnormal_energy_balance | 0.73940900 |
| 120 | MP0001440_abnormal_grooming_behavior | 0.73095256 |
| 121 | MP0001905_abnormal_dopamine_level | 0.71666941 |
| 122 | MP0003959_abnormal_lean_body | 0.70224405 |
| 123 | MP0004147_increased_porphyrin_level | 0.69149452 |
| 124 | MP0003045_fibrosis | 0.68737584 |
| 125 | MP0005085_abnormal_gallbladder_physiolo | 0.68707310 |
| 126 | MP0002160_abnormal_reproductive_system | 0.68332703 |
| 127 | MP0002896_abnormal_bone_mineralization | 0.67924554 |
| 128 | MP0000631_abnormal_neuroendocrine_gland | 0.66877762 |
| 129 | MP0000604_amyloidosis | 0.66778817 |
| 130 | MP0005275_abnormal_skin_tensile | 0.66689966 |
| 131 | MP0008875_abnormal_xenobiotic_pharmacok | 0.66067406 |
| 132 | MP0004924_abnormal_behavior | 0.65972750 |
| 133 | MP0005386_behavior/neurological_phenoty | 0.65972750 |
| 134 | MP0005408_hypopigmentation | 0.64591736 |
| 135 | MP0003638_abnormal_response/metabolism_ | 0.64431734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic seizures (HP:0002173) | 5.02879796 |
| 2 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.61991430 |
| 3 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.61991430 |
| 4 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.47698329 |
| 5 | Symptomatic seizures (HP:0011145) | 4.43336625 |
| 6 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.32811532 |
| 7 | Dysostosis multiplex (HP:0000943) | 4.30680490 |
| 8 | Abnormal ciliary motility (HP:0012262) | 4.29766459 |
| 9 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.29171726 |
| 10 | Hypoglycemic coma (HP:0001325) | 4.22900504 |
| 11 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.17568044 |
| 12 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.14517381 |
| 13 | Absent/shortened dynein arms (HP:0200106) | 4.14517381 |
| 14 | Rhinitis (HP:0012384) | 4.13614310 |
| 15 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.10690969 |
| 16 | Mucopolysacchariduria (HP:0008155) | 4.10690969 |
| 17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.07403214 |
| 18 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.07403214 |
| 19 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.07403214 |
| 20 | Hyperventilation (HP:0002883) | 4.03965709 |
| 21 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.79003036 |
| 22 | Pancreatic cysts (HP:0001737) | 3.58880688 |
| 23 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.54268472 |
| 24 | Pancreatic fibrosis (HP:0100732) | 3.36467425 |
| 25 | True hermaphroditism (HP:0010459) | 3.32344390 |
| 26 | Ketoacidosis (HP:0001993) | 3.26307830 |
| 27 | Papilledema (HP:0001085) | 3.24487801 |
| 28 | Hypothermia (HP:0002045) | 3.22800454 |
| 29 | Complement deficiency (HP:0004431) | 3.18920791 |
| 30 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.18547921 |
| 31 | Medial flaring of the eyebrow (HP:0010747) | 3.13635943 |
| 32 | Decreased circulating renin level (HP:0003351) | 3.07554864 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.07210468 |
| 34 | Vacuolated lymphocytes (HP:0001922) | 3.06858943 |
| 35 | Generalized aminoaciduria (HP:0002909) | 3.05228349 |
| 36 | Abnormality of the renal cortex (HP:0011035) | 3.04324222 |
| 37 | Abnormality of midbrain morphology (HP:0002418) | 3.01353165 |
| 38 | Molar tooth sign on MRI (HP:0002419) | 3.01353165 |
| 39 | Chronic sinusitis (HP:0011109) | 3.01309573 |
| 40 | Bronchiectasis (HP:0002110) | 3.00261725 |
| 41 | Chronic hepatic failure (HP:0100626) | 2.99508830 |
| 42 | Hyperglycemia (HP:0003074) | 2.86931893 |
| 43 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.86860769 |
| 44 | Nephronophthisis (HP:0000090) | 2.85913247 |
| 45 | Gait imbalance (HP:0002141) | 2.83206570 |
| 46 | Agitation (HP:0000713) | 2.78159925 |
| 47 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.77950733 |
| 48 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.77950733 |
| 49 | Congenital primary aphakia (HP:0007707) | 2.70980220 |
| 50 | Visual hallucinations (HP:0002367) | 2.70888178 |
| 51 | Chronic bronchitis (HP:0004469) | 2.64407814 |
| 52 | Abnormality of the renal medulla (HP:0100957) | 2.62380290 |
| 53 | Nephrogenic diabetes insipidus (HP:0009806) | 2.61270586 |
| 54 | Tubular atrophy (HP:0000092) | 2.61202656 |
| 55 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.60802612 |
| 56 | Late onset (HP:0003584) | 2.59596810 |
| 57 | Fat malabsorption (HP:0002630) | 2.55247818 |
| 58 | Prolonged partial thromboplastin time (HP:0003645) | 2.55217566 |
| 59 | Progressive neurologic deterioration (HP:0002344) | 2.49713083 |
| 60 | Cystic liver disease (HP:0006706) | 2.49401506 |
| 61 | Recurrent sinusitis (HP:0011108) | 2.47010029 |
| 62 | Intrahepatic cholestasis (HP:0001406) | 2.45109459 |
| 63 | Hypobetalipoproteinemia (HP:0003563) | 2.43363437 |
| 64 | Metabolic alkalosis (HP:0200114) | 2.42307670 |
| 65 | Abnormal pancreas size (HP:0012094) | 2.42081597 |
| 66 | Growth hormone excess (HP:0000845) | 2.40054420 |
| 67 | Bile duct proliferation (HP:0001408) | 2.37813022 |
| 68 | Abnormal biliary tract physiology (HP:0012439) | 2.37813022 |
| 69 | Glomerulonephritis (HP:0000099) | 2.34423407 |
| 70 | Agammaglobulinemia (HP:0004432) | 2.33969325 |
| 71 | Hyperaldosteronism (HP:0000859) | 2.32029416 |
| 72 | Bronchitis (HP:0012387) | 2.31579575 |
| 73 | Conjugated hyperbilirubinemia (HP:0002908) | 2.31432448 |
| 74 | Fair hair (HP:0002286) | 2.31022187 |
| 75 | Beaking of vertebral bodies (HP:0004568) | 2.30541218 |
| 76 | Renal cortical cysts (HP:0000803) | 2.29679689 |
| 77 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.26932703 |
| 78 | Pheochromocytoma (HP:0002666) | 2.24528638 |
| 79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.24430386 |
| 80 | Alkalosis (HP:0001948) | 2.24144276 |
| 81 | Ketosis (HP:0001946) | 2.24117129 |
| 82 | Hyperphosphatemia (HP:0002905) | 2.24111330 |
| 83 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.21447147 |
| 84 | Large for gestational age (HP:0001520) | 2.20272194 |
| 85 | Abnormality of complement system (HP:0005339) | 2.19606751 |
| 86 | Absent speech (HP:0001344) | 2.19273579 |
| 87 | Hydroxyprolinuria (HP:0003080) | 2.17378722 |
| 88 | Abnormality of proline metabolism (HP:0010907) | 2.17378722 |
| 89 | Male pseudohermaphroditism (HP:0000037) | 2.16457043 |
| 90 | Abnormality of renin-angiotensin system (HP:0000847) | 2.14437943 |
| 91 | Hyperglycinuria (HP:0003108) | 2.12267970 |
| 92 | Furrowed tongue (HP:0000221) | 2.12119728 |
| 93 | Oligomenorrhea (HP:0000876) | 2.10772334 |
| 94 | Concave nail (HP:0001598) | 2.10497326 |
| 95 | Occipital encephalocele (HP:0002085) | 2.10216227 |
| 96 | Genital tract atresia (HP:0001827) | 2.10053508 |
| 97 | Recurrent bronchitis (HP:0002837) | 2.09010161 |
| 98 | Retinal atrophy (HP:0001105) | 2.08617386 |
| 99 | Exocrine pancreatic insufficiency (HP:0001738) | 2.07590399 |
| 100 | EEG with generalized epileptiform discharges (HP:0011198) | 2.06991396 |
| 101 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.06298907 |
| 102 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.06298907 |
| 103 | Abnormal protein glycosylation (HP:0012346) | 2.06298907 |
| 104 | Abnormal glycosylation (HP:0012345) | 2.06298907 |
| 105 | Vaginal atresia (HP:0000148) | 2.06255552 |
| 106 | Tubulointerstitial nephritis (HP:0001970) | 2.05893211 |
| 107 | Hypokalemia (HP:0002900) | 2.05771252 |
| 108 | Nephritis (HP:0000123) | 2.05019712 |
| 109 | Neuroendocrine neoplasm (HP:0100634) | 2.03570467 |
| 110 | Keratoconus (HP:0000563) | 2.02045281 |
| 111 | Increased corneal curvature (HP:0100692) | 2.02045281 |
| 112 | Epileptiform EEG discharges (HP:0011182) | 2.01994426 |
| 113 | Steatorrhea (HP:0002570) | 2.01510861 |
| 114 | Hypsarrhythmia (HP:0002521) | 2.01323907 |
| 115 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.00154020 |
| 116 | Hyperactive renin-angiotensin system (HP:0000841) | 1.99221898 |
| 117 | Supranuclear gaze palsy (HP:0000605) | 1.99011706 |
| 118 | Spondylolisthesis (HP:0003302) | 1.98036676 |
| 119 | Type II lissencephaly (HP:0007260) | 1.96565339 |
| 120 | Irregular vertebral endplates (HP:0003301) | 1.96368043 |
| 121 | Abnormality of vitamin metabolism (HP:0100508) | 1.96313224 |
| 122 | Limb hypertonia (HP:0002509) | 1.94646942 |
| 123 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.94592797 |
| 124 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.94592797 |
| 125 | Abnormality of glycolipid metabolism (HP:0010969) | 1.94592797 |
| 126 | Abnormality of the common coagulation pathway (HP:0010990) | 1.93470178 |
| 127 | Hyperlipoproteinemia (HP:0010980) | 1.93241331 |
| 128 | Vascular calcification (HP:0004934) | 1.89381255 |
| 129 | Congenital, generalized hypertrichosis (HP:0004540) | 1.88920821 |
| 130 | Spinal canal stenosis (HP:0003416) | 1.86169469 |
| 131 | Inability to walk (HP:0002540) | 1.85625384 |
| 132 | Cardiovascular calcification (HP:0011915) | 1.85300066 |
| 133 | Hyperparathyroidism (HP:0000843) | 1.85032793 |
| 134 | Renal salt wasting (HP:0000127) | 1.84936117 |
| 135 | Delayed CNS myelination (HP:0002188) | 1.84930987 |
| 136 | Action tremor (HP:0002345) | 1.84911250 |
| 137 | Torticollis (HP:0000473) | 1.84699509 |
| 138 | Poor coordination (HP:0002370) | 1.84330994 |
| 139 | Tubulointerstitial fibrosis (HP:0005576) | 1.84196465 |
| 140 | Decreased central vision (HP:0007663) | 1.84142379 |
| 141 | Focal motor seizures (HP:0011153) | 1.83960724 |
| 142 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.83409322 |
| 143 | Abnormality of glycine metabolism (HP:0010895) | 1.83409322 |
| 144 | Spontaneous abortion (HP:0005268) | 1.82768873 |
| 145 | Arterial tortuosity (HP:0005116) | 1.82032766 |
| 146 | Neurofibrillary tangles (HP:0002185) | 1.81849168 |
| 147 | Congenital stationary night blindness (HP:0007642) | 1.80900060 |
| 148 | Thoracolumbar scoliosis (HP:0002944) | 1.79834119 |
| 149 | Insulin resistance (HP:0000855) | 1.79403854 |
| 150 | Proximal tubulopathy (HP:0000114) | 1.79179189 |
| 151 | Limb dystonia (HP:0002451) | 1.78911012 |
| 152 | Infertility (HP:0000789) | 1.78514719 |
| 153 | Systemic lupus erythematosus (HP:0002725) | 1.78152577 |
| 154 | Retinal dysplasia (HP:0007973) | 1.77597039 |
| 155 | Tubulointerstitial abnormality (HP:0001969) | 1.77374470 |
| 156 | Barrel-shaped chest (HP:0001552) | 1.76353395 |
| 157 | Vascular tortuosity (HP:0004948) | 1.76349794 |
| 158 | Increased cerebral lipofuscin (HP:0011813) | 1.76066403 |
| 159 | Progressive cerebellar ataxia (HP:0002073) | 1.75621074 |
| 160 | Anxiety (HP:0000739) | 1.74674496 |
| 161 | Abolished electroretinogram (ERG) (HP:0000550) | 1.74210942 |
| 162 | Congenital hepatic fibrosis (HP:0002612) | 1.73652639 |
| 163 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.71756585 |
| 164 | Abnormality of potassium homeostasis (HP:0011042) | 1.70857166 |
| 165 | Abnormal drinking behavior (HP:0030082) | 1.70560683 |
| 166 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.69713844 |
| 167 | Epiphyseal stippling (HP:0010655) | 1.68520300 |
| 168 | Mitral stenosis (HP:0001718) | 1.68417189 |
| 169 | Hypercortisolism (HP:0001578) | 1.64914745 |
| 170 | Abnormality of the fovea (HP:0000493) | 1.64132809 |
| 171 | Myokymia (HP:0002411) | 1.64130268 |
| 172 | Nonprogressive disorder (HP:0003680) | 1.62923174 |
| 173 | Failure to thrive in infancy (HP:0001531) | 1.62684519 |
| 174 | Long toe (HP:0010511) | 1.62656384 |
| 175 | Craniofacial dystonia (HP:0012179) | 1.62473721 |
| 176 | Disproportionate short-trunk short stature (HP:0003521) | 1.61746204 |
| 177 | Generalized hypopigmentation of hair (HP:0011358) | 1.61470002 |
| 178 | Acne (HP:0001061) | 1.60445565 |
| 179 | Focal dystonia (HP:0004373) | 1.59958073 |
| 180 | Asymmetric septal hypertrophy (HP:0001670) | 1.58007330 |
| 181 | Abnormality of the vertebral endplates (HP:0005106) | 1.55605666 |
| 182 | Epileptic encephalopathy (HP:0200134) | 1.55518092 |
| 183 | Abdominal distention (HP:0003270) | 1.55436388 |
| 184 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.55279640 |
| 185 | Gout (HP:0001997) | 1.55194524 |
| 186 | Hyperkalemia (HP:0002153) | 1.54727303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.45993864 |
| 2 | TAOK3 | 3.91028470 |
| 3 | ACVR1B | 3.31411463 |
| 4 | CASK | 3.25900382 |
| 5 | ERN1 | 2.75195930 |
| 6 | MAP3K13 | 2.48512586 |
| 7 | KSR2 | 2.35329096 |
| 8 | ARAF | 2.26825013 |
| 9 | PRKD3 | 2.26137699 |
| 10 | CAMKK2 | 2.23470494 |
| 11 | GRK1 | 2.22722872 |
| 12 | MAP3K9 | 2.15635808 |
| 13 | MAP4K2 | 2.09067276 |
| 14 | BMPR1B | 2.08222335 |
| 15 | MAPK15 | 2.05711029 |
| 16 | STK39 | 2.01702940 |
| 17 | MST4 | 2.00484919 |
| 18 | NTRK3 | 1.96713143 |
| 19 | FRK | 1.94348623 |
| 20 | ADRBK2 | 1.93343919 |
| 21 | OXSR1 | 1.88424874 |
| 22 | HIPK2 | 1.87146849 |
| 23 | WNK3 | 1.86657713 |
| 24 | MAP3K2 | 1.85723174 |
| 25 | PASK | 1.80262006 |
| 26 | FLT3 | 1.80241915 |
| 27 | NTRK1 | 1.79049017 |
| 28 | BCR | 1.77003177 |
| 29 | STK38L | 1.71766775 |
| 30 | STK24 | 1.71566606 |
| 31 | BMPR2 | 1.47440473 |
| 32 | MAP3K12 | 1.40693722 |
| 33 | MARK1 | 1.40614690 |
| 34 | CAMKK1 | 1.36575302 |
| 35 | MAP3K1 | 1.33367592 |
| 36 | BCKDK | 1.28560855 |
| 37 | MAP2K7 | 1.28307848 |
| 38 | ERBB3 | 1.27650896 |
| 39 | PRKCH | 1.24545163 |
| 40 | MUSK | 1.24035783 |
| 41 | FGFR2 | 1.22320714 |
| 42 | PRKD2 | 1.21085677 |
| 43 | MAPKAPK3 | 1.15499819 |
| 44 | RIPK4 | 1.13970317 |
| 45 | TLK1 | 1.12860323 |
| 46 | SGK2 | 1.10624796 |
| 47 | RAF1 | 1.07947275 |
| 48 | PIK3CG | 1.07878627 |
| 49 | MYLK | 1.06600963 |
| 50 | SGK494 | 1.03743366 |
| 51 | SGK223 | 1.03743366 |
| 52 | BRAF | 1.02409534 |
| 53 | TEC | 1.02144641 |
| 54 | MAPK13 | 1.01394065 |
| 55 | TNK2 | 1.00837716 |
| 56 | MAP3K4 | 0.99860721 |
| 57 | EPHA2 | 0.97204269 |
| 58 | RET | 0.96593097 |
| 59 | KIT | 0.94391346 |
| 60 | SCYL2 | 0.94267180 |
| 61 | LIMK1 | 0.93848507 |
| 62 | ADRBK1 | 0.93693031 |
| 63 | EPHA4 | 0.93312302 |
| 64 | NEK9 | 0.90953353 |
| 65 | PRKCG | 0.88670932 |
| 66 | AKT3 | 0.87964659 |
| 67 | TRIM28 | 0.86178265 |
| 68 | CHUK | 0.85047625 |
| 69 | SGK3 | 0.78338457 |
| 70 | NUAK1 | 0.77699531 |
| 71 | PRKCI | 0.77242151 |
| 72 | WNK4 | 0.76596145 |
| 73 | PRKCZ | 0.75873093 |
| 74 | MAP2K4 | 0.72929890 |
| 75 | PAK3 | 0.72460680 |
| 76 | IRAK3 | 0.71522369 |
| 77 | SYK | 0.71489795 |
| 78 | EPHA3 | 0.70866614 |
| 79 | MAP2K1 | 0.70237712 |
| 80 | TAOK1 | 0.69525724 |
| 81 | BTK | 0.68665938 |
| 82 | CSNK1G2 | 0.68155980 |
| 83 | RPS6KA2 | 0.67766367 |
| 84 | JAK1 | 0.66680700 |
| 85 | SIK3 | 0.66665602 |
| 86 | MINK1 | 0.66635752 |
| 87 | EIF2AK3 | 0.66186046 |
| 88 | JAK3 | 0.65495418 |
| 89 | CDC42BPA | 0.64299452 |
| 90 | ERBB2 | 0.64052272 |
| 91 | PDK1 | 0.63549931 |
| 92 | PRKAA2 | 0.62681852 |
| 93 | PINK1 | 0.62372068 |
| 94 | MOS | 0.62330479 |
| 95 | NEK6 | 0.61973212 |
| 96 | PDPK1 | 0.60728925 |
| 97 | SIK1 | 0.60447259 |
| 98 | PRKCE | 0.60402713 |
| 99 | KSR1 | 0.58875166 |
| 100 | MAPKAPK5 | 0.58774230 |
| 101 | MARK2 | 0.58309963 |
| 102 | CDK5 | 0.56852557 |
| 103 | STK3 | 0.56823834 |
| 104 | PHKG2 | 0.56710221 |
| 105 | PHKG1 | 0.56710221 |
| 106 | FES | 0.56690886 |
| 107 | JAK2 | 0.55852425 |
| 108 | DAPK2 | 0.55115538 |
| 109 | TNIK | 0.54271247 |
| 110 | PIK3CA | 0.53893690 |
| 111 | PAK6 | 0.51658752 |
| 112 | CDK8 | 0.51640600 |
| 113 | TGFBR1 | 0.51425995 |
| 114 | DMPK | 0.51126684 |
| 115 | FGFR3 | 0.51023333 |
| 116 | TESK1 | 0.50212526 |
| 117 | PRKCQ | 0.50192137 |
| 118 | CAMK2D | 0.49700521 |
| 119 | ZAP70 | 0.49037699 |
| 120 | CSF1R | 0.48578935 |
| 121 | CSNK1A1 | 0.48242338 |
| 122 | NLK | 0.48166001 |
| 123 | PRKACA | 0.47790779 |
| 124 | CAMK2A | 0.47336910 |
| 125 | CAMK1 | 0.46881629 |
| 126 | UHMK1 | 0.46026633 |
| 127 | PRKD1 | 0.45532034 |
| 128 | MAP3K7 | 0.45376739 |
| 129 | FER | 0.45336283 |
| 130 | DYRK2 | 0.45171663 |
| 131 | MAP3K6 | 0.45023773 |
| 132 | PRKCA | 0.44820003 |
| 133 | PTK2 | 0.43884399 |
| 134 | TRPM7 | 0.43692094 |
| 135 | IKBKE | 0.43667460 |
| 136 | WNK1 | 0.43163611 |
| 137 | CSNK1G1 | 0.42758665 |
| 138 | IRAK4 | 0.41463703 |
| 139 | PTK2B | 0.41224662 |
| 140 | CSNK1G3 | 0.41124980 |
| 141 | ABL1 | 0.41067231 |
| 142 | RPS6KB1 | 0.40668136 |
| 143 | TBK1 | 0.40514304 |
| 144 | SIK2 | 0.40506204 |
| 145 | MAP2K2 | 0.39103298 |
| 146 | GRK5 | 0.39050317 |
| 147 | CAMK2B | 0.38676068 |
| 148 | MAP2K6 | 0.37872376 |
| 149 | LMTK2 | 0.37643402 |
| 150 | DYRK1B | 0.37610221 |
| 151 | CDK9 | 0.37059765 |
| 152 | PRKAA1 | 0.36176982 |
| 153 | STK38 | 0.35828079 |
| 154 | PKN1 | 0.35274647 |
| 155 | ZAK | 0.35181636 |
| 156 | PRKG1 | 0.34950121 |
| 157 | IGF1R | 0.33995470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.68661401 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.87964197 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.67597844 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26056410 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.08017951 |
| 6 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.81036729 |
| 7 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.77073163 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.76401315 |
| 9 | Retinol metabolism_Homo sapiens_hsa00830 | 2.63191448 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.60528409 |
| 11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.55903056 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.43988754 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.34502528 |
| 14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.24259274 |
| 15 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.13826890 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.94277263 |
| 17 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.83179495 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.82274369 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.77789398 |
| 20 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.73261512 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72571006 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.71913149 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58404812 |
| 24 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.56932111 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.56884242 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.56236508 |
| 27 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.56097212 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54761518 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.51373116 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.49511578 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.47517378 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.43504497 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.43018203 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.41402868 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.40983615 |
| 36 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.40433768 |
| 37 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.35936517 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.35628776 |
| 39 | Circadian entrainment_Homo sapiens_hsa04713 | 1.33972807 |
| 40 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.32405755 |
| 41 | Long-term potentiation_Homo sapiens_hsa04720 | 1.28020294 |
| 42 | Circadian rhythm_Homo sapiens_hsa04710 | 1.21919371 |
| 43 | GABAergic synapse_Homo sapiens_hsa04727 | 1.19058143 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.18008365 |
| 45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.16764834 |
| 46 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.16487520 |
| 47 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.15985658 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.15558425 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12062207 |
| 50 | Taste transduction_Homo sapiens_hsa04742 | 1.11415619 |
| 51 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.10969496 |
| 52 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.10171646 |
| 53 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.09531343 |
| 54 | Morphine addiction_Homo sapiens_hsa05032 | 1.08848528 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.05897243 |
| 56 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.05126235 |
| 57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04257874 |
| 58 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.03603338 |
| 59 | Olfactory transduction_Homo sapiens_hsa04740 | 1.02482625 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98751923 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.98519350 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98478933 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98137671 |
| 64 | Mineral absorption_Homo sapiens_hsa04978 | 0.98039044 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97891775 |
| 66 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.96405693 |
| 67 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94853288 |
| 68 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91787871 |
| 69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.91513114 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.85725056 |
| 71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84717000 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84324483 |
| 73 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.82026500 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81982648 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.81425073 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.81016013 |
| 77 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80673962 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80230344 |
| 79 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79107549 |
| 80 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.78422437 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78263359 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77203140 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.76469173 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75796701 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.72763743 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72224432 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70767497 |
| 88 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.70076947 |
| 89 | Phototransduction_Homo sapiens_hsa04744 | 0.69760995 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.69654296 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.69565616 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.69251950 |
| 93 | Nicotine addiction_Homo sapiens_hsa05033 | 0.68816904 |
| 94 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.68638043 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.67163563 |
| 96 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64867822 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64052136 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62863523 |
| 99 | Long-term depression_Homo sapiens_hsa04730 | 0.62632888 |
| 100 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61878090 |
| 101 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61606279 |
| 102 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.60990739 |
| 103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60004861 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57053678 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56408825 |
| 106 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.56150368 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55245833 |
| 108 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54413759 |
| 109 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54135592 |
| 110 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.53777829 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53162247 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52831883 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51661112 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51288357 |
| 115 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51049434 |
| 116 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.50604164 |
| 117 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.50566280 |
| 118 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.50094430 |
| 119 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48499611 |
| 120 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47788325 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45248266 |
| 122 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44126473 |
| 123 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44012004 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43871493 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.43552833 |
| 126 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42695598 |
| 127 | Glioma_Homo sapiens_hsa05214 | 0.42587839 |
| 128 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42412116 |
| 129 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41562964 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40612194 |
| 131 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40544750 |
| 132 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39657192 |
| 133 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.39455662 |
| 134 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39439277 |
| 135 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39201604 |
| 136 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.38543033 |
| 137 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38425733 |
| 138 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.38259975 |
| 139 | Allograft rejection_Homo sapiens_hsa05330 | 0.36380242 |
| 140 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35423443 |
| 141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35151172 |
| 142 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35049314 |
| 143 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.34560355 |
| 144 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33066950 |
| 145 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31766742 |
| 146 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.30878909 |
| 147 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30478672 |
| 148 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30472321 |
| 149 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.30462731 |
| 150 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.30417770 |
| 151 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29582078 |
| 152 | Phagosome_Homo sapiens_hsa04145 | 0.29281596 |
| 153 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.28394019 |
| 154 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.27025318 |

